Epidemiological characteristics, clinical presentations, and prognoses of pediatric brain tumors: Experiences of national center for children's health
- PMID: 36776329
- PMCID: PMC9915562
- DOI: 10.3389/fonc.2023.1067858
Epidemiological characteristics, clinical presentations, and prognoses of pediatric brain tumors: Experiences of national center for children's health
Abstract
Background: We aimed to describe the epidemiological characteristics, clinical presentations, and prognoses in a national health center for children.
Methods: From January 2015 to December 2020, 484 patients aged 0-16 years, who were diagnosed with brain tumors and received neurosurgery treatment, were enrolled in the study. Pathology was based on the World Health Organization 2021 nervous system tumor classification, and tumor behaviors were classified according to the International Classification of Diseases for Oncology, third edition.
Results: Among the 484 patients with brain tumors, the median age at diagnosis was 4.62 [2.19, 8.17] years (benign tumors 4.07 [1.64, 7.13] vs. malignant tumors 5.36 [2.78, 8.84], p=0.008). The overall male-to-female ratio was 1.33:1(benign 1.09:1 vs. malignant 1.62:1, p=0.029). Nausea, vomiting, and headache were the most frequent initial symptoms. The three most frequent tumor types were embryonal tumors (ET, 22.8%), circumscribed astrocytic gliomas (20.0%), and pediatric-type diffuse gliomas (11.0%). The most common tumor locations were the cerebellum and fourth ventricle (38.67%), the sellar region (22.9%) and ventricles (10.6%). Males took up a higher proportion than females in choroid plexus tumors (63.6%), ET (61.1%), ependymal tumors (68.6%), and germ cell tumors (GCTs, 78.1%). Patients were followed for 1 to 82 months. The overall 5-year survival rate was 77.5%, with survival rates of 91.0% for benign tumors and 64.6% for malignant tumors.
Conclusion: Brain tumors presented particularly sex-, age-, and regional-dependent epidemiological characteristics. Our results were consistent with previous reports and might reflect the real epidemiological status in China.
Keywords: brain tumor; children; clinical presentation; epidemiology; prognosis.
Copyright © 2023 Yang, Cai, Chen, Yang, Ying, Liang, Ling, Zhu, Sun, Ji, Peng, Zhang, Ma and Ge.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer NJ declared a shared parent affiliation with the authors to the handling editor at the time of review.
Figures




Similar articles
-
The epidemiology of primary and metastatic brain tumors in infancy through childhood.J Neurooncol. 2022 Jan;156(2):419-429. doi: 10.1007/s11060-021-03927-z. Epub 2022 Jan 17. J Neurooncol. 2022. PMID: 35037155
-
Epidemiology of nervous system tumors in children: a survey of 1,485 cases in Beijing Tiantan Hospital from 2001 to 2005.Pediatr Neurosurg. 2008;44(2):97-103. doi: 10.1159/000113110. Epub 2008 Jan 24. Pediatr Neurosurg. 2008. PMID: 18230922
-
Epidemiological characteristics of central nervous system tumors in children: a 5-year review of 3180 cases from Beijing Tiantan Hospital.Chin Neurosurg J. 2022 May 12;8(1):11. doi: 10.1186/s41016-022-00279-z. Chin Neurosurg J. 2022. PMID: 35550659 Free PMC article.
-
Central nervous system.Cancer Biomark. 2010;9(1-6):193-210. doi: 10.3233/CBM-2011-0177. Cancer Biomark. 2010. PMID: 22112477 Review.
-
Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type.Front Oncol. 2023 Jan 16;12:1082062. doi: 10.3389/fonc.2022.1082062. eCollection 2022. Front Oncol. 2023. PMID: 36727064 Free PMC article. Review.
Cited by
-
Association of tumor location with anxiety and depression in childhood brain cancer survivors: a systematic review and meta-analysis.Child Adolesc Psychiatry Ment Health. 2023 Oct 27;17(1):124. doi: 10.1186/s13034-023-00665-0. Child Adolesc Psychiatry Ment Health. 2023. PMID: 37891679 Free PMC article. Review.
-
Exploring neonatal brain tumors: a narrative review about epidemiology, classification, and management.Ann Med Surg (Lond). 2025 Apr 2;87(5):2838-2846. doi: 10.1097/MS9.0000000000003229. eCollection 2025 May. Ann Med Surg (Lond). 2025. PMID: 40337379 Free PMC article. Review.
-
Pyrimidine compounds BY4003 and BY4008 inhibit glioblastoma cells growth via modulating JAK3/STAT3 signaling pathway.Neurotherapeutics. 2024 Sep;21(5):e00431. doi: 10.1016/j.neurot.2024.e00431. Epub 2024 Aug 16. Neurotherapeutics. 2024. PMID: 39153914 Free PMC article.
-
Predictors of postoperative complications and functional outcomes in pediatric patients with surgically treated fourth ventricle tumors.Acta Neurochir (Wien). 2023 Dec;165(12):4279-4292. doi: 10.1007/s00701-023-05729-w. Epub 2023 Aug 3. Acta Neurochir (Wien). 2023. PMID: 37535206
-
Computerized assessment of neuropsychological functioning in pediatric brain tumor patients.J Neurooncol. 2025 May;172(3):633-644. doi: 10.1007/s11060-025-04945-x. Epub 2025 Jan 31. J Neurooncol. 2025. PMID: 39888549
References
-
- Ostrom QT, de Blank PM, Kruchko C, Petersen CM, Liao P, Finlay JL, et al. . Alex's lemonade stand foundation infant and childhood primary brain and central nervous system tumors diagnosed in the united states in 2007–2011. Neuro-Oncology (2014) 16:x1–x36. doi: 10.1093/neuonc/nou327 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources